Calidi Biotherapeutics (CLDI) Share-based Compensation (2022 - 2025)
Calidi Biotherapeutics' Share-based Compensation came in at $450,000 for Q4 2025, down 28.1% from $626,000 a year earlier and down 14.9% from the prior quarter.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Share-based Compensation (2022 - 2025) Analysis & Trends
For FY2025, Calidi Biotherapeutics' Share-based Compensation was $2.11 million, down 28.7% from FY2024.
- Share-based Compensation carries a three-year compound annual growth rate of -22.5% (FY2022 to FY2025).
- Going back by year, Share-based Compensation was $2.96 million in FY2024 (-38.5%), $4.81 million in FY2023 (+6.3%) and $4.52 million in FY2022.
- The Q4 2025 figure represents the lowest quarterly Share-based Compensation in data going back to Q4 2022.
- Year-over-year, Share-based Compensation has declined for eight consecutive quarters, with an average decline of 33.4% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q4 2023 (growth of 12.1%), and the weakest in Q4 2024 (a decline of 47.2%).
- Business Quant data shows CLDI's Share-based Compensation at $529,000 (Q3 2025), $522,000 (Q2 2025) and $607,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Calidi Biotherapeutics | 907,797.59 | -24.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 529,000.00 |
| Jun 30, 2025 | 522,000.00 |
| Mar 31, 2025 | 607,000.00 |
| Dec 31, 2024 | 626,000.00 |
| Sep 30, 2024 | 691,000.00 |
| Jun 30, 2024 | 751,000.00 |
| Mar 31, 2024 | 888,000.00 |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.06 Mn |
API Access
Calidi Biotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();